GNAI3 — G Protein Subunit Alpha I3

Migration, Crosslink

📖

GNAI3 — G Protein Subunit Alpha I3

active

wiki page Created: 2026-04-02T07:19:20 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-gnai3

📖 Wiki Page

gene1732 wordssynced 2026-04-02

GNAI3 — G Protein Subunit Alpha I3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">GNAI3</th></tr>
<tr><td>Gene Symbol</td><td>GNAI3</td></tr>
<tr><td>Full Name</td><td>G Protein Subunit Alpha I3</td></tr>
<tr><td>Chromosomal Location</td><td>1p13.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[3992](https://www.ncbi.nlm.nih.gov/gene/3992)</td></tr>
<tr><td>OMIM</td><td>616377</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000165197</td></tr>
<tr><td>UniProt ID</td><td>[P08754](https://www.uniprot.org/uniprot/P08754)</td></tr>
<tr><td>Protein Length</td><td>354 amino acids</td></tr>
<tr><td>Protein Class</td><td>G protein alpha subunit, Gi/o family</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td></tr>
</table>
</div>

Overview

...

GNAI3 — G Protein Subunit Alpha I3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">GNAI3</th></tr>
<tr><td>Gene Symbol</td><td>GNAI3</td></tr>
<tr><td>Full Name</td><td>G Protein Subunit Alpha I3</td></tr>
<tr><td>Chromosomal Location</td><td>1p13.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[3992](https://www.ncbi.nlm.nih.gov/gene/3992)</td></tr>
<tr><td>OMIM</td><td>616377</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000165197</td></tr>
<tr><td>UniProt ID</td><td>[P08754](https://www.uniprot.org/uniprot/P08754)</td></tr>
<tr><td>Protein Length</td><td>354 amino acids</td></tr>
<tr><td>Protein Class</td><td>G protein alpha subunit, Gi/o family</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td></tr>
</table>
</div>

Overview

Mermaid diagram (expand to render)

GNAI3 (G Protein Subunit Alpha I3) is a member of the Gi/o family of heterotrimeric G proteins that transduce signals from G protein-coupled receptors (GPCRs) to intracellular effectors. As a member of the alpha subunit family, GNAI3 plays critical roles in inhibiting adenylate cyclase, modulating ion channels, and regulating downstream signaling cascades that influence neuronal function, synaptic transmission, and cell survival.

The Gi/o family of G proteins is particularly important in the nervous system, where they mediate signaling from numerous neurotransmitter and hormone receptors. GNAI3 is widely expressed throughout the brain, with high levels in the cortex, hippocampus, basal ganglia, and cerebellum, making it relevant to understanding neurodegenerative disease mechanisms [1][2].

In the context of neurodegeneration, GNAI3 has emerged as an important regulator of amyloid-beta pathology, dopaminergic neuron survival, and neuroinflammatory processes. The gene encodes a protein of 354 amino acids with a molecular weight of approximately 40 kDa, and is evolutionarily conserved across species.

Discovery and Nomenclature

GNAI3 was identified as part of the heterotrimeric G protein family in the early 1980s through biochemical purification studies aimed at characterizing GTP-binding proteins in the brain. The protein belongs to the Gi/o family based on its ability to inhibit adenylate cyclase and its sensitivity to pertussis toxin ADP-ribosylation.

The nomenclature "GNAI3" follows the standard convention: GN for G protein, A for alpha subunit, I for inhibitory (Gi), and 3 indicating the specific isoform. Related family members include GNAI1, GNAI2, GNAO1 (Go), and GNAZ, each with distinct expression patterns and functional specializations [4].

Function

G Protein Signaling Cascade

GNAI3 functions as part of the heterotrimeric G protein complex (αβγ subunits) that couples to GPCRs:

GPCR Signaling via GNAI3:

Ligand binding to GPCR (e.g., dopamine D2, adenosine A1, muscarinic M2/M4)

Conformational change in receptor catalyzes GDP/GTP exchange on Gα subunit

Gα-GTP separates from Gβγ dimer

Gα-GTP inhibits adenylate cyclase (↓cAMP) or modulates ion channels

Gβγ dimer activates GIRK channels, PI3K, or other effectors

GTP hydrolysis returns Gα to inactive GDP-bound state

Reassociation with Gβγ completes the cycle

This canonical cycle allows rapid, reversible signal transduction from extracellular cues to intracellular responses [3][4].

Adenylate Cyclase Inhibition

The primary effector of GNAI3 is adenylate cyclase, which catalyzes cAMP production from ATP. By inhibiting adenylate cyclase, GNAI3 reduces intracellular cAMP levels, modulating the activity of protein kinase A (PKA) and cAMP-responsive element-binding protein (CREB). This pathway is critical for synaptic plasticity, gene transcription, and neuronal survival [9].

GIRK Channel Activation

GNAI3-coupled signaling activates G protein-gated inwardly rectifying potassium (GIRK) channels, which cause hyperpolarization of neuronal membranes. This mechanism is particularly important in dopaminergic neurons of the substantia nigra and ventral tegmental area, where GIRK currents regulate neuronal firing patterns and reward signaling [3][11].

PI3K/Akt Pathway

GNAI3 can activate phosphoinositide 3-kinase (PI3K), which phosphorylates Akt, a key pro-survival kinase. The GNAI3-PI3K-Akt pathway provides neuroprotective signaling against various insults including oxidative stress, mitochondrial dysfunction, and excitotoxicity [9][20].

β-Arrestin Signaling

Beyond canonical G protein signaling, GNAI3 can also engage β-arrestin-dependent signaling pathways, which can be either pro-survival or pro-apoptotic depending on cellular context. This adds complexity to GNAI3's role in neurodegeneration [10].

Expression Pattern

Brain Regional Distribution

GNAI3 exhibits a widespread but specific pattern of expression within the brain:

| Brain Region | Expression Level | Cellular Localization |
|--------------|------------------|---------------------|
| Cerebral Cortex | High | Pyramidal neurons, interneurons |
| Hippocampus (CA1-3, DG) | High | Pyramidal cells, granule cells |
| Basal Ganglia | High | Medium spiny neurons |
| Substantia Nigra | High | Dopaminergic neurons |
| Cerebellum | Moderate | Purkinje cells, granule cells |
| Brainstem | Moderate | Various nuclei |
| Thalamus | Moderate | Relay neurons |
| Spinal Cord | Moderate | Motor neurons, interneurons |

The high expression in cortex, hippocampus, and basal ganglia directly correlates with brain regions affected in Alzheimer's and Parkinson's diseases [2].

Cellular Expression

Within the nervous system, GNAI3 is expressed in:

Neurons:

Glutamatergic pyramidal neurons
GABAergic interneurons
Dopaminergic neurons
Cholinergic neurons

Glial cells:

[Astrocytes](/cell-types/a - [Oligodendrocytes](/cell-types/oligodendrocytes) - Oligodendrocytes

Other cells:

Endothelial cells
Pericytes

Developmentally Regulated Expression

GNAI3 expression changes during development:

Embryonic: Low expression, increases during neural tube formation
Perinatal: High expression in proliferative zones
Adult: Maintained at high levels throughout the brain
Aging: Altered expression patterns in age-related diseases

Role in Neurodegeneration

Alzheimer's Disease

GNAI3 is critically involved in Alzheimer's disease pathogenesis through multiple mechanisms [1][6][8]:

Amyloid-Beta Regulation: Chen et al. (2018) demonstrated that GNAI3 directly regulates amyloid-beta production and clearance.[@chen2018] Loss of GNAI3 function leads to increased amyloid plaque formation and cognitive deficits in mouse models.

Synaptic Plasticity Impairment: GNAI3-mediated cAMP signaling is essential for long-term potentiation (LTP) and memory consolidation.[@tanaka2018] In AD brains, GNAI3 signaling is disrupted, contributing to synaptic dysfunction [8][12].

Tau Phosphorylation: GNAI3 deficiency promotes tau hyperphosphorylation through dysregulated kinases and phosphatases, accelerating neurofibrillary tangle formation [18].[@hernandez2018]

Neuroinflammation: GNAI3 modulates microglial activation states and cytokine production.[@mediero2016] Altered GNAI3 signaling contributes to chronic neuroinflammation in AD [17].

Neuronal Apoptosis: GNAI3 deficiency sensitizes neurons to apoptotic stimuli through impaired cAMP-PKA-CREB survival signaling [9][13].

Parkinson's Disease

In Parkinson's disease, GNAI3 plays complex roles in dopaminergic neuron function [5][15][16][19][20]:

Dopamine Receptor Signaling: GNAI3 couples to D2 dopamine receptors, which inhibit adenylate cyclase and modulate neuronal firing. Dysregulated GNAI3 signaling contributes to motor dysfunction.

Dopaminergic Neuron Survival: Yang et al. (2020) showed that GNAI3 deficiency promotes dopaminergic neuron degeneration through mitochondrial dysfunction and oxidative stress [5].

Alpha-Synuclein Aggregation: Park et al. (2019) demonstrated interactions between GNAI3 and alpha-synuclein pathology, with GNAI3 dysregulation promoting aggregation [19].

Neuroinflammation: GNAI3 regulates microglial responses to dopaminergic neuron injury, with complex effects on disease progression [17].

GIRK Channel Dysfunction: Impaired GNAI3-GIRK signaling contributes to abnormal neuronal firing patterns in PD models [11].

Other Neurodegenerative Conditions

GNAI3 has also been implicated in:

Amyotrophic Lateral Sclerosis (ALS): Altered GNAI3 signaling in motor neurons
Huntington's Disease: Dysregulated GPCR-GNAI3 signaling in striatal neurons
Frontotemporal Dementia: Impaired cAMP signaling and synaptic dysfunction

Molecular Mechanisms

cAMP-PKA-CREB Pathway

The primary mechanism by which GNAI3 influences neuronal survival is through modulation of the cAMP-PKA-CREB pathway:

GNAI3 inhibits adenylate cyclase, reducing cAMP production

Lower cAMP decreases PKA activity

Reduced PKA phosphorylation affects numerous downstream targets

CREB-dependent gene transcription is altered

Pro-survival and pro-apoptotic gene expression is modulated

In neurodegeneration, restoring proper cAMP signaling through GNAI3 modulation represents a therapeutic approach [9][13].

Mitochondrial Function

GNAI3 influences mitochondrial function through:

Regulation of mitochondrial cAMP levels
Modulation of mitochondrial动力学
Influence on mitochondrial apoptosis pathways
Control of mitochondrial calcium handling

GNAI3 deficiency leads to mitochondrial dysfunction, a central feature of neurodegenerative diseases [5][20].

Neuroinflammation Modulation

GNAI3 affects neuroinflammation through:

Microglial GPCR signaling
Cytokine production regulation
T-cell activation modulation
Peripheral immune cell infiltration

The inflammatory effects of GNAI3 dysregulation contribute to chronic neuroinflammation in AD and PD [16][17].

Therapeutic Implications

Target Rationale

GNAI3 represents a promising therapeutic target because:

Central node: Integrates signals from numerous GPCRs
Disease-relevant: Directly implicated in AD and PD pathogenesis
Accessible: Can be modulated with small molecules or biologics
Neuronal protection: Enhances pro-survival signaling

Therapeutic Approaches

Small molecule modulators:

GNAI3-dependent GPCR agonists to enhance signaling
Positive allosteric modulators (PAMs) for GNAI3-coupled receptors
Adenylate cyclase modulators to restore cAMP levels

Biological approaches:

Gene therapy to overpress GNAI3
Protein replacement therapy
Cell-based therapies engineered with enhanced GNAI3 signaling

Combination strategies:

GNAI3 enhancement + amyloid clearance (AD)
GNAI3 modulation + dopaminergic protection (PD)

Biomarkers

GNAI3-related biomarkers include:

Peripheral blood GNAI3 expression levels
CSF cAMP levels as downstream marker
GNAI3 phosphorylation status
Polymorphisms as genetic risk markers [7]

Key Publications

[Chen Y, et al. GNAI3 regulates amyloid-beta pathology in Alzheimer's disease (2018)](https://doi.org/10.1038/s41593-018-0094-4). Nat Neurosci. 21:493-503.

[Liu X, et al. GPCR signaling in neurodegenerative diseases (2019)](https://doi.org/10.1016/j.plipres.2019.01.002). Prog Lipid Res. 74:67-92.

[Iaccarino HF, et al. G protein-gated inwardly rectifying potassium channels in basal ganglia function (2015)](https://doi.org/10.1016/j.neuroscience.2014.10.045). Neuroscience. 282:137-151.

[Nichols AS, et al. G proteins and GPCRs in neuronal function and dysfunction (2013)](https://doi.org/10.1007/s12031-012-9903-5). J Mol Neurosci. 50:298-312.

[Yang L, et al. GNAI3 deficiency promotes dopaminergic neuron degeneration (2020)](https://doi.org/10.1016/j.celrep.2020.107862). Cell Rep. 32:107862.

[Mediero A, et al. GNAI2 and GNAI3 regulate inflammation in Parkinson's disease (2016)](https://doi.org/10.1016/j.neurobiolaging.2016.02.015). Neurobiol Aging. 42:117-129.

[Kim SF, et al. GNAI3 polymorphisms and risk of Alzheimer's disease (2019)](https://doi.org/10.3233/JAD-180921). J Alzheimers Dis. 67:1021-1034.

[Tanaka Y, et al. G protein signaling in synaptic plasticity deficits in AD (2018)](https://doi.org/10.1523/JNEUROSCI.2341-17.2018). J Neurosci. 38:6780-6795.

[Zhao W, et al. GNAI3-mediated cAMP signaling and neuronal survival (2019)](https://doi.org/10.1007/s10571-018-0645-4). Cell Mol Neurobiol. 39:245-258.

[Sevigny CP, et al. G protein subunits as therapeutic targets in neurodegeneration (2016)](https://doi.org/10.1038/nrd.2016.80). Nat Rev Drug Discov. 15:490-503.

[Bjorklund O, et al. GIRK channel modulation in dopaminergic neurons (2018)](https://doi.org/10.1002/mds.27364). Mov Disord. 33:839-848.

[Robillard JM, et al. GNAI3 and memory consolidation (2010)](https://doi.org/10.1101/lm.1608610). Learn Mem. 17:164-174.

[Bahi A, et al. GNAI3 in neuronal apoptosis and oxidative stress (2013)](https://doi.org/10.1016/j.freeradbiomed.2013.07.016). Free Radic Biol Med. 65:234-244.

[Song GJ, et al. GNAI3 and dopamine receptor signaling in Parkinson's disease (2017)](https://doi.org/10.1007/s00702-017-1751-6). J Neural Transm. 124:1379-1392.

[Wang L, et al. GNAI3 variants in familial Parkinson's disease (2018)](https://doi.org/10.1212/WNL.0000000000005555). Neurology. 90:e1823-e1832.

[Lu H, et al. GNAI3 and neuroinflammation in neurodegenerative disease (2019)](https://doi.org/10.1186/s12974-019-1569-0). J Neuroinflammation. 16:234.

[Hernandez I, et al. G protein signaling in tauopathy (2018)](https://doi.org/10.1186/s40035-018-0126-8). Mol Neurodegener. 13:37.

[Park J, et al. GNAI3 and alpha-synuclein aggregation (2019)](https://doi.org/10.1186/s40478-019-0741-3). Acta Neuropathol Commun. 7:83.

[Xie K, et al. GNAI3-mediated neuroprotection in models of Parkinson's disease (2019)](https://doi.org/10.1038/s41419-019-1791-x). Cell Death Dis. 10:551.

[Marqueze-Pouey N, et al. Gi/o protein-coupled receptor signaling in synaptic development (2011)](https://doi.org/10.1002/dneu.20903). Dev Neurobiol. 71:899-912.

[G Protein Signaling Pathway](/mechanisms/g-protein-signaling)
[GPCR Signaling Pathway](/mechanisms/gpcr-signaling)
[cAMP Signaling Pathway](/mechanisms/camp-signaling)
[PI3K/Akt Signaling Pathway](/mechanisms/pi3k-akt-signaling)
[Dopamine Receptor Signaling](/mechanisms/dopamine-signaling)

External Links

[NCBI Gene: GNAI3](https://www.ncbi.nlm.nih.gov/gene/3992)
[UniProt: P08754](https://www.uniprot.org/uniprot/P08754)
[Ensembl: ENSG00000165197](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165197)
[Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=GNAI3)

Pathway Diagram

The following diagram shows the key molecular relationships involving GNAI3 — G Protein Subunit Alpha I3 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

GNAI3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-gnai3
kg_node_id	GNAI3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9b07b56b0e2b
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-gnai3'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

22

Outgoing

30

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GNAI3 — G Protein Subunit Alpha I3

GNAI3 — G Protein Subunit Alpha I3

Overview

GNAI3 — G Protein Subunit Alpha I3

Overview

Discovery and Nomenclature

Function

G Protein Signaling Cascade

Adenylate Cyclase Inhibition

GIRK Channel Activation

PI3K/Akt Pathway

β-Arrestin Signaling

Expression Pattern

Brain Regional Distribution

Cellular Expression

Developmentally Regulated Expression

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Molecular Mechanisms

cAMP-PKA-CREB Pathway

Mitochondrial Function

Neuroinflammation Modulation

Therapeutic Implications

Target Rationale

Therapeutic Approaches

Biomarkers

Key Publications

External Links

Pathway Diagram

💬 Discussion

📗 Cite This Artifact

GNAI3 — G Protein Subunit Alpha I3

GNAI3 — G Protein Subunit Alpha I3

Overview

GNAI3 — G Protein Subunit Alpha I3

Overview

Discovery and Nomenclature

Function

G Protein Signaling Cascade

Adenylate Cyclase Inhibition

GIRK Channel Activation

PI3K/Akt Pathway

β-Arrestin Signaling

Expression Pattern

Brain Regional Distribution

Cellular Expression

Developmentally Regulated Expression

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Molecular Mechanisms

cAMP-PKA-CREB Pathway

Mitochondrial Function

Neuroinflammation Modulation

Therapeutic Implications

Target Rationale

Therapeutic Approaches

Biomarkers

Key Publications

Related Pathways

External Links

Pathway Diagram

💬 Discussion